1.

Hepatitis B Prevention & Clinical Management Guidelines

* Immunization Schedules for U.S.-Bound Refugees administered by the
International Organization for Migration, Aug 2014 (Immigrant, Refugee and Migrant
Health Branch, Division of Global Migration and Quarantine, CDC)
* Guidelines for the Prevention, Care, and Treatment of Persons with Chronic
Hepatitis B Infection (World Health Organization, March 2015)
* Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American
Society of Clinical Oncology Provisional Clinical Opinion Update (January 2015)
* Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During
Immunosuppressive Drug Therapy (American Gastroenterological Association,
October 2014)
2. Hepatitis C News & Resources
* A Guide to Comprehensive Hepatitis C Counseling and Testingin Primary Care
Settings (CDC)
* Local Health Departments and Hepatitis C (National Association of City and County
Health Officials, Webinar, May 2015)
* Implementing Electronic Medical Record Prompts for Baby Boomer Hep C
Screening (National Viral Hepatitis Roundtable, 2015)
* Patients infected with hepatitis C after visiting Santa Barbara doctor (LA Times,
April 28, 2015)
* New Hepatitis C Treatments Have High Cure Rates for African Americans
(AIDS.gov, April 24, 2015)
3. Hepatitis C State Policy Updates
* CalHEP recommends nearly $9 million of hepatitis C health care assistance for
Californians in next years state budget (Project Inform, May 10, 2015)
* The Governors May Revision for the 2015-2016 Budget includes $228 million for
hepatitis C treatment costs in Medi-Cal, state hospitals, and state prisons. If
finalized, the budget would be effective July 1.
* Assembly Bill 383 (Gipson, D-Carson) would require primary care clinics to offer
hepatitis C screening in accordance with U.S. Preventive Services Task Force
screening guidelines, with some exceptions noted in the bill. For more information
and to read the bill, visit leginfo.legislature.ca.gov/.

4. Hepatitis C and HIV/HCV Coinfection Clinical Management Updates

* FDA Label Update: Olysio (simeprevir) (FDA, April, 2015) (1) serious symptomatic
bradycardia when co-administered with sofosbuvir and amiodarone; and (2) hepatic
decompensation and hepatic failure.
* FDA Safety Alert: Hepatitis C Treatments Containing Sofosbuvir in Combination
With Another Direct Acting Antiviral Drug: Serious Slowing of Heart Rate When Used
With Antiarrhythmic Drug Amiodarone.
* California Correctional Health Care Services, HCV Care Guide (Updated May 2015)
* Delivering Hepatitis C Treatment in an HIV Care Setting (HRSA, 2014)
* AASLD/IDSA HCV Treatment Guidelines, HIV Coinfection Section Updated (March
2015)
5. Care and Treatment Resources
* Pharmaceutical Company Patient Assistance Programs for Treatment of Hepatitis B
and Hepatitis C (National Alliance of State and Territorial AIDS Directors, February
2015)
* Blue Cross Withholds Cure from Hepatitis C Patients, Lawsuit Claims (PR Newswire,
May 15, 2015)
* Your Health Care Rights (California Department of Managed Care)